Briacell Therapeutics Corp Stock Buy Hold or Sell Recommendation
| BCTX Stock | USD 0.73 0.06 7.59% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Briacell Therapeutics Corp is 'Cautious Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Briacell Therapeutics Corp given historical horizon and risk tolerance towards Briacell Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Briacell Therapeutics Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Briacell Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Briacell and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Briacell Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Briacell |
Execute Briacell Therapeutics Buy or Sell Advice
The Briacell recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Briacell Therapeutics Corp. Macroaxis does not own or have any residual interests in Briacell Therapeutics Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Briacell Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Briacell Therapeutics Trading Alerts and Improvement Suggestions
| Briacell Therapeutics had very high historical volatility over the last 90 days | |
| Briacell Therapeutics has some characteristics of a very speculative penny stock | |
| Briacell Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (4.93 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Briacell Therapeutics Corp currently holds about 41.04 M in cash with (24.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Briacell Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company shares are held by company insiders |
Briacell Therapeutics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Briacell analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Briacell analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Briacell Therapeutics Returns Distribution Density
The distribution of Briacell Therapeutics' historical returns is an attempt to chart the uncertainty of Briacell Therapeutics' future price movements. The chart of the probability distribution of Briacell Therapeutics daily returns describes the distribution of returns around its average expected value. We use Briacell Therapeutics Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Briacell Therapeutics returns is essential to provide solid investment advice for Briacell Therapeutics.
| Mean Return | 0.39 | Value At Risk | -11.11 | Potential Upside | 23.94 | Standard Deviation | 10.93 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Briacell Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Briacell Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Briacell Therapeutics, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Briacell Therapeutics Corp back and forth among themselves.
| Shares | Group One Trading, Lp | 2024-06-30 | 10.9 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 5.3 K | Royal Bank Of Canada | 2024-06-30 | 3.8 K | Td Waterhouse Canada Inc | 2024-06-30 | 2.9 K | Advisor Group Holdings, Inc. | 2024-06-30 | 1 K | Hhm Wealth Advisors, Llc | 2024-09-30 | 1000 | Tower Research Capital Llc | 2024-06-30 | 528 | Sabby Management Llc | 2024-06-30 | 0.0 | Citadel Advisors Llc | 2024-09-30 | 0.0 | Bank Of Montreal | 2024-06-30 | 56.3 K | Bmo Capital Markets Corp. | 2024-06-30 | 56.3 K |
Briacell Therapeutics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (124.3K) | 57.2M | (16.2M) | (19.8M) | (20.4M) | (19.4M) | |
| Free Cash Flow | (1.2M) | (7.7M) | (12.5M) | (23.7M) | (24.6M) | (23.4M) | |
| Other Non Cash Items | 64.7K | 1.8M | 11.7M | (1.1M) | (28.0M) | (26.6M) | |
| Net Income | (3.7M) | (428.3K) | (26.8M) | (20.3M) | (4.9M) | (5.2M) | |
| End Period Cash Flow | 19.5K | 57.3M | 41.0M | 21.3M | 862.1K | 819.0K | |
| Depreciation | 14.0K | 15.3K | 15.3K | 15.3K | 83.9K | 88.1K | |
| Investments | (591.0K) | 1.3M | 31.0K | 0.0 | (681.8K) | (647.7K) | |
| Change To Netincome | (360.0K) | 88.8K | (5.1M) | 14.7M | 16.9M | 17.8M |
Briacell Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Briacell Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Briacell Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Briacell stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.37 | |
β | Beta against Dow Jones | 0.05 | |
σ | Overall volatility | 10.99 | |
Ir | Information ratio | 0.02 |
Briacell Therapeutics Volatility Alert
Briacell Therapeutics Corp is displaying above-average volatility over the selected time horizon. Briacell Therapeutics Corp is a potential penny stock. Although Briacell Therapeutics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Briacell Therapeutics Corp. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Briacell instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Briacell Therapeutics Fundamentals Vs Peers
Comparing Briacell Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Briacell Therapeutics' direct or indirect competition across all of the common fundamentals between Briacell Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Briacell Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Briacell Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Briacell Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Briacell Therapeutics to competition |
| Fundamentals | Briacell Therapeutics | Peer Average |
| Return On Equity | -2.06 | -0.31 |
| Return On Asset | -1.26 | -0.14 |
| Current Valuation | 25.28 M | 16.62 B |
| Shares Outstanding | 36.18 M | 571.82 M |
| Shares Owned By Insiders | 19.60 % | 10.09 % |
| Shares Owned By Institutions | 12.88 % | 39.21 % |
| Number Of Shares Shorted | 745.07 K | 4.71 M |
| Price To Book | 17.03 X | 9.51 X |
| EBITDA | (4.77 M) | 3.9 B |
| Net Income | (4.93 M) | 570.98 M |
| Cash And Equivalents | 41.04 M | 2.7 B |
| Cash Per Share | 2.64 X | 5.01 X |
| Total Debt | 8.56 M | 5.32 B |
| Current Ratio | 45.00 X | 2.16 X |
| Book Value Per Share | (0.13) X | 1.93 K |
| Cash Flow From Operations | (24.13 M) | 971.22 M |
| Short Ratio | 0.20 X | 4.00 X |
| Earnings Per Share | (0.29) X | 3.12 X |
| Target Price | 15.0 | |
| Beta | 1.82 | -0.15 |
| Market Capitalization | 26.4 M | 19.03 B |
| Total Asset | 5.87 M | 29.47 B |
| Retained Earnings | (85.44 M) | 9.33 B |
| Working Capital | (3.81 M) | 1.48 B |
| Net Asset | 5.87 M |
Note: Disposition of 50000 shares by Embro-pantalony Vaughn C. of Briacell Therapeutics at 8.47 subject to Rule 16b-3 [view details]
Briacell Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Briacell . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Briacell Therapeutics Buy or Sell Advice
When is the right time to buy or sell Briacell Therapeutics Corp? Buying financial instruments such as Briacell Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2023 | 2024 (projected) | Working Capital | 402.0K | 357.4K | Market Cap | 92.5M | 97.1M |
Use Investing Ideas to Build Portfolios
In addition to having Briacell Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Russia On Wall Street Thematic Idea Now
Russia On Wall Street
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Briacell Stock Analysis
When running Briacell Therapeutics' price analysis, check to measure Briacell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Briacell Therapeutics is operating at the current time. Most of Briacell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Briacell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Briacell Therapeutics' price. Additionally, you may evaluate how the addition of Briacell Therapeutics to your portfolios can decrease your overall portfolio volatility.